arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Gevo, Inc.

GEVO
$1.55 ▲ +0.11 (+7.64%) at close
Materials ·Industrial Organic Chemicals ·USIndustrial Organic Chemicals
21 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
37
Health
Weak
Bearish
auto_awesome

Analytical Summary

Gevo, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $362.7M
Dividend Yield
Revenue Growth 849.3%
Op. Margin -12.6%
ROIC -2.5%
FCF / Share $-0.19
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity 0.35
info Valuation on last close. End-of-day price, Aug 7, 2026.

21-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$160.58M
↑ +849.3%
Net Income Profit after all expenses
$-33.84M
↑ +57.0%
Operating Margin Operating profit as % of sales
-12.6%
↑ +97.4% 13th
FCF / Share Free cash flow per share
$-0.19
↑ +60.3%
Long-Term Debt Long-term obligations
$164.75M
↑ +145.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
10
Returns
36
Financial Health
52
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 21 years · 70 quarters